Evidence map›Paper›PMID 36064769›Full record

ArticleEye (London, England)2023

Treat & extend in neovascular age-related macular degeneration: how we got here and where do we go next?

Varun Chaudhary, Chair, Retina Evidence Trials InterNational Alliance (R.E.T.I.N.A.) Study Group

Abstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Eye (London, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Aflibercept 8 mg for diabetic macular edema and neovascular age-related macular degeneration: an italian expert consensus paper.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Article
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Varun ChaudharyDepartment of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada. vchaudh@mcmaster.ca.ORCID 0000-0002-9988-4146
Chair, Retina Evidence Trials InterNational Alliance (R.E.T.I.N.A.) Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Macular DegenerationWet Macular DegenerationAngiogenesis InhibitorsHumansIntravitreal InjectionsRanibizumabTomography, Optical CoherenceTreatment OutcomeAngiogenesis InhibitorsRanibizumab

Identifiers

PMID36064769
PMCPMC9998426

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.